DUGGAN ROBERT W 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-13 5:54 pm Purchase |
2024-09-11 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 555,736,060 75.200% |
379,871,779 (+216.00%) |
Filing |
| 2023-02-16 4:01 pm Unchanged |
2023-02-07 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 175,864,281 78.100% |
0 (Unchanged) |
Filing |
| 2022-12-09 5:24 pm Purchase |
2022-12-06 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 175,864,281 81.800% |
9,346,434 (+5.61%) |
Filing |
| 2022-08-18 4:43 pm Purchase |
2022-08-16 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 166,517,847 81.150% |
94,870,338 (+132.41%) |
Filing |
| 2021-05-14 4:27 pm Purchase |
2021-05-12 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 71,647,509 70.780% |
11,365,921 (+18.85%) |
Filing |
| 2021-04-22 5:11 pm Unchanged |
2021-04-20 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.370% |
0 (Unchanged) |
Filing |
| 2021-03-26 5:07 pm Unchanged |
2021-03-24 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.370% |
0 (Unchanged) |
Filing |
| 2020-11-10 4:11 pm Purchase |
2020-11-06 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 60,281,588 69.940% |
4,341,317 (+7.76%) |
Filing |
| 2020-10-06 7:28 pm Purchase |
2020-10-02 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 55,940,271 69.110% |
9,730,539 (+21.06%) |
Filing |
| 2020-09-28 4:37 pm Purchase |
2020-09-18 | 13D | Summit Therapeutics Inc. SMMT |
DUGGAN ROBERT W | 46,209,732 64.890% |
46,209,732 (New Position) |
Filing |